cc-TDI Collaborates Globally with Atomwise
We proudly announce our global Artificial Intelligence (AI) collaboration with Atomwise, resulting in a new publication in the journal Scientific Reports. The paper, “AI is
We proudly announce our global Artificial Intelligence (AI) collaboration with Atomwise, resulting in a new publication in the journal Scientific Reports. The paper, “AI is
The Children’s Cancer Therapy Development Institute (cc-TDI) proudly announces its partnership with Team KOODAC (Knock Out Oncogenic Drivers and Curing Childhood Cancer), a global interdisciplinary
We are excited to update you on entinostat, a therapy that’s traveled through cc-TDI’s development pipeline in the fight against rhabdomyosarcoma (RMS). Entinostat is a breast
cc-TDI welcomed Claire Newman to cc-TDI as a Social Venture Partners Encore Fellow in August 2023. Claire’s role in Operations Scaling and Optimization includes diving
The Silicon Forest in Hillsboro, OR, January 9, 2024 – The Children’s Cancer Therapy Development Institute was awarded $100,000 in continued support of two research
As we make our final approach to the new year, we want to share a story that embodies the #givingbackchildhood spirit of cc-TDI’s mission. Meet
In August 2023, the cc-TDI team was introduced to the Bliss family, a vibrant and loving family who wanted to make a difference in the
In fond remembrance of Ally Anderson, we joyfully celebrate a life that, despite the challenges of pediatric cancer, radiated hope, love, and an unwavering spirit.
Like most of the world, Jessie Munoz didn’t know much about childhood cancer. She had seen the St. Jude commercials of the smiling bald babies,
[Press Release] The Silicon Forest in Hillsboro, OR, October 3, 2023 – The Children’s Cancer Therapy Development Institute was recently awarded $70,000 in continued support
We proudly announce our global Artificial Intelligence (AI) collaboration with Atomwise, resulting in a new publication in the journal Scientific Reports. The paper, “AI is
The Children’s Cancer Therapy Development Institute (cc-TDI) proudly announces its partnership with Team KOODAC (Knock Out Oncogenic Drivers and Curing Childhood Cancer), a global interdisciplinary
We are excited to update you on entinostat, a therapy that’s traveled through cc-TDI’s development pipeline in the fight against rhabdomyosarcoma (RMS). Entinostat is a breast
cc-TDI welcomed Claire Newman to cc-TDI as a Social Venture Partners Encore Fellow in August 2023. Claire’s role in Operations Scaling and Optimization includes diving
The Silicon Forest in Hillsboro, OR, January 9, 2024 – The Children’s Cancer Therapy Development Institute was awarded $100,000 in continued support of two research
As we make our final approach to the new year, we want to share a story that embodies the #givingbackchildhood spirit of cc-TDI’s mission. Meet
In August 2023, the cc-TDI team was introduced to the Bliss family, a vibrant and loving family who wanted to make a difference in the
In fond remembrance of Ally Anderson, we joyfully celebrate a life that, despite the challenges of pediatric cancer, radiated hope, love, and an unwavering spirit.
Like most of the world, Jessie Munoz didn’t know much about childhood cancer. She had seen the St. Jude commercials of the smiling bald babies,
[Press Release] The Silicon Forest in Hillsboro, OR, October 3, 2023 – The Children’s Cancer Therapy Development Institute was recently awarded $70,000 in continued support
EIN: 46-5759569
cc-TDI is a qualified 501(c)(3) charitable organization registered with the IRS
(consult with a CPA regarding specific tax implications)
Copyright 2023 – Children’s Cancer Therapy Development Institute